AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 6088300
Drug: Indomethacin 75
RxNorm normalized name: indomethacin 75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indomethacin 75 mg daily
Trial: 31364144
Drug: Oral supplements
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral supplements (OS) with immune-stimulating molecules (Group 2 and 3)
Trial: 31364144
Drug: Standard treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard treatment for rhinitis and OME (Control group)
Trial: 28715908
Drug: Prolonged exposure
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prolonged exposure treatment (N=36)
Trial: 16884344
Drug: Control (n
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (n = 22) - no treatment
Trial: 14626377
Drug: Short-term hormone
RxNorm normalized name: hydrogen peroxide
DrugBank: Hydrogen peroxide (DB11091)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Short-term hormone therapy (HT)
Trial: 19505307
Drug: Postmenopausal hormone
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Postmenopausal hormone therapy (HT)
Trial: 1390495
Drug: Cyclophosphamide 1
RxNorm normalized name: cyclophosphamide 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclophosphamide 1 g intravenous boluses monthly
Trial: 3893815
Drug: Indobufen 100
RxNorm normalized name: indobufen
DrugBank: Indobufen (DB12545)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indobufen 100 mg b.d.
Trial: 3893815
Drug: Indobufen 200
RxNorm normalized name: indobufen 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indobufen 200 mg b.d.
Trial: 27682493
Drug: Compound monoammonium
RxNorm normalized name: BENZOIN COMPOUND
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Compound monoammonium glycyrrhizinate combined with dandelion (TCM group)
Trial: 29771077
Drug: Routine treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine treatment (Control group)
Trial: 18625920
Drug: SPs making
RxNorm normalized name: SPS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SPs making brand-specific medication requests
Trial: 11822921
Drug: 2 mL
RxNorm normalized name: ethanol 2 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mL of hyaluronate sodium at a concentration of 10 mg/mL
Trial: 31995811
Drug: Varenicline administration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Varenicline administration
Trial: 28459236
Drug: 6 g/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6 g/day sugarcane bagasse plus conventional treatment
Trial: 20015433
Drug: Placebo plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo plus conventional treatment
Trial: 24481688
Drug: B vitamin
RxNorm normalized name: B-50 Hi Potency B Vitamins
FDA approved: no
EMA approved: no
PMDA approved: no
Description: B vitamin supplementation (220 μg folic acid, 1.1 mg vitamin B2, 0.73 mg B6, 1.2 μg B12, 130 mg calcium)
Trial: 24742970
Drug: Aliskiren (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aliskiren (150 mg/day)
Trial: 24742970
Drug: Combined aliskiren
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined aliskiren (150 mg/day) and losartan (100 mg/day)
Trial: 6756484
Drug: No‐treatment control
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No‐treatment control group
Trial: 10886592
Drug: R‐568 (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: R‐568 (100 mg)
Trial: 1559738
Drug: Cefadroxil 500
RxNorm normalized name: cefadroxil 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefadroxil 500 mg twice daily
Trial: 3902362
Drug: PGE2 (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PGE2 (0.5 mg) administered every 4 h via nasogastric tube
Trial: 30469412
Drug: Synergy 1
RxNorm normalized name: Senergy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Synergy 1 (10 g/day)
Trial: 26111826
Drug: Continuous-fingolimod 0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous-fingolimod 0.5 mg
Trial: 22910291
Drug: Oral vitamin
RxNorm normalized name: vitamin A Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral vitamin D3 treatment for 1 year
Trial: 17969401
Drug: Endocrine therapy
RxNorm normalized name: ENDOCRINE THERAPY
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Endocrine therapy with aromatase inhibitors (anastrazole or exemestane)
Trial: 11793169
Drug: Menatetrenone (45
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Menatetrenone (45 mg/day, daily; n = 23)
Trial: 11793169
Drug: Etidronate (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Etidronate (200 mg/day, 14 days per 3 months; n = 25)
Trial: 11793169
Drug: Calcium lactate
RxNorm normalized name: Calcium Lactate
DrugBank: Calcium lactate (DB13231)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium lactate (2 g/day, daily; n = 24)
Trial: 8005130
Drug: verapamil 360
RxNorm normalized name: verapamil 360 mg/24 hours oral capsule, extended release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: verapamil 360 mg.day-1
Trial: 2679444
Drug: Gestrinone (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gestrinone (2 x 2.5 mg/week)
Trial: 2679444
Drug: Danazol (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Danazol (3 x 200 mg/day)
Trial: 23647007
Drug: Tx 4:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tx 4: no further treatment (control)
Trial: 19860888
Drug: 0.5% PRO
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5% PRO 2000/5 gel
Trial: 16032448
Drug: CEI (Conventional
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CEI (Conventional continuous epidural infusion)
Trial: 12399689
Drug: Daily supervised
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily supervised brushing with 1,500-ppm fluoride toothpaste and rinsing with a beaker of water (School A)
Trial: 12399689
Drug: Daily supervised
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily supervised brushing with 1,500-ppm fluoride toothpaste and only permitted to spit out once after brushing (School B)
Trial: 12399689
Drug: No daily
RxNorm normalized name: Aveeno Daily Moisturizing
DrugBank: Dimethicone (DB11074)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: No daily brushing and no supply of toothpaste (School C)
Trial: 30138384
Drug: Ranibizumab monotherapy
RxNorm normalized name: Ranibizumab
DrugBank: Ranibizumab (DB01270)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Ranibizumab monotherapy
Trial: 19190496
Drug: 18-month lamivudine
RxNorm normalized name: Lamivudine
DrugBank: Lamivudine (DB00709)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: 18-month lamivudine monotherapy
Trial: 17259157
Drug: Estrogen (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Estrogen (3 mg estrostilben thrice a day from the day before acrinol injection to the end of delivery)
Trial: 10329858
Drug: Control (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (no estrogen treatment)
Trial: 11501645
Drug: Cream A
RxNorm normalized name: KIT, CREAM AND GEL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cream A (high lipid content)
Trial: 11501645
Drug: Cream B
RxNorm normalized name: Cream Base
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cream B (moderate/low lipid content)
Trial: 24009792
Drug: Annual mass
RxNorm normalized name: annual bluegrass pollen extract
DrugBank: Poa annua pollen (DB10353)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Annual mass drug administration (MDA) aiming for coverage of children between 80%-90%
Trial: 24009792
Drug: Annual mass
RxNorm normalized name: annual bluegrass pollen extract
DrugBank: Poa annua pollen (DB10353)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Annual mass drug administration (MDA) aiming for coverage > 90%
Trial: 24009792
Drug: Annual mass
RxNorm normalized name: annual bluegrass pollen extract
DrugBank: Poa annua pollen (DB10353)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Annual mass drug administration (MDA) for three years
Trial: 21315216
Drug: CCM plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CCM plus optimal medical therapy (OMT)
Trial: 18990434
Drug: 75 mg
RxNorm normalized name: talc 75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 75 mg aspirin with 150 mg clopidogrel
Trial: 18990434
Drug: 160 mg
RxNorm normalized name: nadolol 160 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 160 mg aspirin with 150 mg clopidogrel
Trial: 15526839
Drug: Intranasal salmon
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal salmon calcitonin (200 IU, thrice a week)
Trial: 15526839
Drug: Calcium carbonate
RxNorm normalized name: Calcium Carbonate
DrugBank: Calcium carbonate (DB06724)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Calcium carbonate (up to 6 g/d) alone or with aluminum hydroxide (up to 3 g/d) as phosphate binders
Trial: 1616360
Drug: Intranasal salmon
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal salmon calcitonin
Trial: 2936636
Drug: Topical application
RxNorm normalized name: Talc Topical application Powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical application of 1% isoconazole nitrate in the morning followed in the evening by 5% benzoyl peroxide
Trial: 20384968
Drug: SR oxycodone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SR oxycodone
Trial: 12424549
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg oxazepam
Trial: 24293756
Drug: Vestipitant (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vestipitant (15 mg)
Trial: 17009541
Drug: Oral Chinese
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral Chinese medicine with massage
Trial: 17009541
Drug: Oral Chinese
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral Chinese medicine only
Trial: 28403910
Drug: Jaungo applied
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Jaungo applied twice a day for 3 weeks
Trial: 23307204
Drug: CC‐IFA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CC‐IFA
Trial: 12940868
Drug: Mix25 twice
RxNorm normalized name: Tice BCG
DrugBank: Bacillus calmette-guerin substrain tice live antigen (DB10343)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mix25 twice daily (Mix25 before both breakfast and evening meal)
Trial: 11130522
Drug: Calcium antagonists
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium antagonists (n=12,699)
Trial: 11130522
Drug: Other antihypertensive
RxNorm normalized name: Other antihypertensives
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Other antihypertensive drugs (n=15,044)
Trial: 24123134
Drug: Vitamin D3
RxNorm normalized name: Vitamin D3
DrugBank: Cholecalciferol (DB00169)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D3 at 200 IU/day (low dose)
Trial: 24123134
Drug: Vitamin D3
RxNorm normalized name: Vitamin D3
DrugBank: Cholecalciferol (DB00169)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D3 at 2000 IU/day (high dose)
Trial: 22045128
Drug: Rocuronium 0.6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rocuronium 0.6 mg/kg at the corrugator supercilii muscle
Trial: 22045128
Drug: Rocuronium 0.6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rocuronium 0.6 mg/kg at the orbicularis oris muscle
Trial: 22045128
Drug: Rocuronium 0.6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rocuronium 0.6 mg/kg at the orbicularis oris and corrugator supercilii muscles
Trial: 2979691
Drug: Placebo preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo preparation
Trial: 27624173
Drug: 1.25 mg
RxNorm normalized name: menthol 1.25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.25 mg Bevacizumab plus 300 µg/0.1 mL Diclofenac (IVB/D)
Trial: 27624173
Drug: 1.25 mg
RxNorm normalized name: menthol 1.25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.25 mg intravitreal Bevacizumab (IVB)
Trial: 25445103
Drug: 3 ml
RxNorm normalized name: WATER,INHL 3 ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 ml of EMLA (lidocaine-prilocaine cream)
Trial: 25445103
Drug: 3 ml
RxNorm normalized name: WATER,INHL 3 ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 ml of placebo
Trial: 19225139
Drug: Folate and
RxNorm normalized name: Folate and/or folate derivative
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Folate and betaine treatment
Trial: 8907095
Drug: 2 mg
RxNorm normalized name: iodine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg of nicotine polacrilex
Trial: 7594291
Drug: Steroid injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Steroid injection with lidocaine
Trial: 2329813
Drug: Chronic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chronic treatment with total triterpenic fraction of Centella asiatica (60 mg twice daily for 7 days)
Trial: 6990745
Drug: Inhalation isoetharine
RxNorm normalized name: isoetharine Inhalation Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhalation isoetharine hydrochloride
Trial: 31276265
Drug: 0.1% mometasone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.1% mometasone furoate (MF) cream + LA‐Cer‐containing moisturizer
Trial: 29726361
Drug: 0.1% mometasone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.1% mometasone furoate (MF) cream
Trial: 28142364
Drug: Usual physical
RxNorm normalized name: hypochlorite
DrugBank: Hypochlorite (DB11123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Usual physical therapy (Control)
Trial: 21208922
Drug: 2 doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 doses of varicella vaccine
Trial: 19046724
Drug: Exemestane 25
RxNorm normalized name: exemestane 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exemestane 25 mg/day
Trial: 15310086
Drug: Megamin (3.6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Megamin (3.6 g daily for 6 to 8 weeks)
Trial: 15310086
Drug: Lycopenomin (1.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lycopenomin (1.2 g daily for 6 to 8 weeks)
Trial: 12520630
Drug: ReN1869 (3.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ReN1869 (3.5 to 95 mg)
Trial: 2528841
Drug: Ketanserin (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketanserin (20 mg t.i.d. for 1 month, 40 mg t.i.d. thereafter; n = 63 patients)
Trial: 756476
Drug: Brief psychotherapy
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Brief psychotherapy and behavior therapy
Trial: 28851088
Drug: ALA-DAG (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ALA-DAG (2.5 g/d for 12 weeks)
Trial: 20615317
Drug: Rush build-up
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rush build-up schedule with Depigoid-SCIT (0.2 mL on day 1, 0.3 mL on day 1, 0.5 mL on day 28)
Trial: 16170235
Drug: Flunitrazepam (6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flunitrazepam (6 mg/70 kg)
Trial: 16170235
Drug: Triazolam (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triazolam (1 and 2 mg/70 kg)
Trial: 8542104
Drug: Azelastine 6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azelastine 6 mg twice per day
Trial: 1922236
Drug: Maintenance therapy
RxNorm normalized name: Dental Resources Perio Maintenance Rinse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maintenance therapy with cyclophosphamide, methotrexate, and fluorouracil
Trial: 1922236
Drug: Observation (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Observation (no further treatment) followed by reinduction therapy with cyclophosphamide, methotrexate, and fluorouracil
Trial: 1922236
Drug: Reinduction therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reinduction therapy with cyclophosphamide, methotrexate, and fluorouracil
Trial: 1922236
Drug: Overall survival
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Overall survival for maintenance therapy group
Trial: 6405607
Drug: Copper supplement
RxNorm normalized name: Copper supplement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Copper supplement (80 micrograms/kg/day as sulphate)
Trial: 23661044
Drug: Subconjunctival bevacizumab
RxNorm normalized name: Bevacizumab
DrugBank: Bevacizumab (DB00112)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Subconjunctival bevacizumab (2.5 mg/0.1 mL)
Trial: 16891588
Drug: 17-mg hydrocortisone
RxNorm normalized name: Hydrocortisone 17-valerate
DrugBank: Hydrocortisone valerate (DB14544)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 17-mg hydrocortisone
Trial: 17542944
Drug: Melatonin (1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Melatonin (1.5 mg)
Trial: 10910871
Drug: 0.1 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.1 mg/kg melatonin
Trial: 17122221
Drug: 0.2 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.2 mg/kg melatonin
Trial: 31190751
Drug: 0.1 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.1 mg/kg midazolam
Trial: 1313637
Drug: Doxycycline, 100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxycycline, 100 mg twice a day for 10 days
Trial: 1313637
Drug: Amoxicillin/probenecid or
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin/probenecid or doxycycline extended treatment if symptoms were still present at 10 days
Trial: 1313637
Drug: Overall treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Overall treatment effectiveness of the three regimens
Trial: 17208082
Drug: Long-term low-molecular-weight
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Long-term low-molecular-weight heparin (LMWH) therapy (tinzaparin)
Trial: 17208082
Drug: Usual care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Usual care (vitamin K antagonist therapy)
Trial: 31522334
Drug: Tacrolimus ointment
RxNorm normalized name: Tacrolimus Ointment
DrugBank: Tacrolimus (DB00864)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tacrolimus ointment 0.03%
Trial: 11524191
Drug: Topical lidocaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical lidocaine hydrochloride 2%
Trial: 9627287
Drug: Salpingectomy followed
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Salpingectomy followed by IVF with combined GnRH agonist and hMG therapy
Trial: 31928931
Drug: Multivalent HIV
RxNorm normalized name: HIV Integrase Inhibitor
DrugBank: HIV Integrase Inhibitor (DB16114)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multivalent HIV vaccine comprising envelope protein with either DNA or NYVAC vectors
Trial: 20078487
Drug: Pregabalin (450
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pregabalin (450 mg/day)
Trial: 10193230
Drug: EMLA patch
RxNorm normalized name: lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: EMLA patch
Trial: 30552275
Drug: Chocolate containing
RxNorm normalized name: chocolate allergenic extract
DrugBank: Cocoa (DB10977)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chocolate containing 99% cocoa, 10g daily for 6 months
Trial: 25163019
Drug: Valacyclovir 1
RxNorm normalized name: valacyclovir 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valacyclovir 1 g twice daily
Trial: 10102256
Drug: Sibutramine 15
RxNorm normalized name: sibutramine 15 mg oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sibutramine 15 mg/day
Trial: 12421835
Drug: Maternal vitamin
RxNorm normalized name: Vitamin A
DrugBank: Vitamin A (DB00162)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maternal vitamin A supplementation (60 mg retinol palmitate at 18-42 days postpartum)
Trial: 12421835
Drug: Infant vitamin
RxNorm normalized name: Leader Infant Vitamin D 400 International Units/mL Drops (Cherry)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Infant vitamin A supplementation (7.5 mg at 6, 10, and 14 weeks of age)
Trial: 10592404
Drug: Transcutaneous electrical
RxNorm normalized name: Transcutaneous Electrical Nerve Stimulators (TENS Units) MISCELL EACH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transcutaneous electrical nerve stimulation (TENS), given once daily for 1 week
Trial: 31724501
Drug: Chlorhexidine brush-on
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlorhexidine brush-on gel
Trial: 21576473
Drug: NVP-containing treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NVP-containing treatment arm
Trial: 21576473
Drug: lopinavir/ritonavir-containing treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: lopinavir/ritonavir-containing treatment arm
Trial: 11314153
Drug: Onerous procedures
RxNorm normalized name: hydrocortisone
DrugBank: Hydrocortisone succinate (DB14545)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Onerous procedures (such as intramuscular injections)
Trial: 8001531
Drug: Drink A
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drink A (90 mmol.l-1 glucose solution)
Trial: 8001531
Drug: Drink B
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drink B (60 mmol.l-1 sodium chloride)
Trial: 28692122
Drug: IL-18 gene
RxNorm normalized name: Ile
DrugBank: Isoleucine (DB00167)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: IL-18 gene polymorphisms -656 G/T and -607 C/A
Trial: 28327988
Drug: Nilotinib 400
RxNorm normalized name: Nilotinib
DrugBank: Nilotinib (DB04868)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nilotinib 400 mg twice daily
Trial: 2864221
Drug: Beta 2‐agonist
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beta 2‐agonist therapy alone
Trial: 2864221
Drug: Beta 2‐agonist
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beta 2‐agonist therapy in combination with theophylline
Trial: 2864221
Drug: Beta 2‐agonist
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beta 2‐agonist therapy in combination with enprofylline
Trial: 31138577
Drug: Cefoperazone-sulbactam (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefoperazone-sulbactam (2 g of each per 12 h)
Trial: 31138577
Drug: Cefepime (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefepime (2 g per 12 h)
Trial: 27840383
Drug: Alogliptin 25
RxNorm normalized name: alogliptin 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alogliptin 25 mg/day
Trial: 27840383
Drug: Alogliptin 25
RxNorm normalized name: alogliptin 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alogliptin 25 mg/day (switch from sitagliptin)